HKSE - Delayed Quote
HKD
Hansoh Pharmaceutical Group Company Limited (3692.HK)
34.860
+0.060
(+0.17%)
At close: 4:08:03 PM GMT+8
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
|
Purchases
|
0 | 0 |
|
Sales
|
-- | 0 |
|
Net Shares Purchased (Sold)
|
0 | 0 |
|
Total Insider Shares Held
|
4.82B | -- |
|
% Net Shares Purchased (Sold)
|
-- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -12,773,807 |
| % Change in Institutional Shares Held | -1.65% |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Lyu (Aifeng) Director (Executive) |
Conversion at price 0.43 per share. | Direct | 37,349 | Jun 27, 2026 |
| Sun (Yuan) Director (Executive) |
Other at price 3.66 per share. | Direct | 1,567,995 | Jun 27, 2026 |
| Lyu (Aifeng) Director (Executive) |
Conversion at price 0.36 per share. | Direct | 64,561 | Apr 29, 2026 |
| Lyu (Aifeng) Director (Executive) |
Conversion at price 0.58 per share. | Direct | 37,837 | Apr 29, 2026 |
| Lyu (Aifeng) Director (Executive) |
Sale at price 5.07 per share. | Direct | 1,521,060 | Apr 20, 2026 |
| Lyu (Aifeng) Director (Executive) |
Conversion at price 0.43 per share. | Direct | 32,031 | Jun 27, 2025 |
| Sun (Yuan) Director (Executive) |
Conversion at price 0.43 per share. | Direct | 61,669 | Jun 27, 2025 |
| Lyu (Aifeng) Director (Executive) |
Conversion at price 0.34 per share. | Direct | 41,468 | Apr 29, 2025 |
| Lyu (Aifeng) Director (Executive) |
Conversion at price 0.37 per share. | Direct | 54,351 | Apr 29, 2025 |
| Sun (Yuan) Director (Executive) |
Conversion at price 0.34 per share. | Direct | 132,733 | Apr 29, 2025 |
| Sun (Yuan) Director (Executive) |
Conversion at price 0.37 per share. | Direct | 157,014 | Apr 29, 2025 |
